The search found 4075 results.
Imprivata®, Inc., the leader in secure access and collaboration for healthcare, today announced that 91 English NHS Trusts, 4 of the Trusts in Northern Ireland and Scotland's entire NHS system are using Imprivata OneSign to provide clinicians with improved workflow and data security, driving productivity and improving patient service. Imprivata's UK market share has grown rapidly with customers including Central and North West London NHS Foundation Trusts and Gloucestershire Hospitals NHS Foundation Trust coming on board recently.
As many as 91 English NHS Trusts, three of the Trusts in Northern Ireland and Scotland's entire NHS system are using Imprivata OneSign to provide clinicians with improved workflow and data security, driving productivity and improving patient service.
Read this customer success story to learn how Mercy Health System reduced password headaches and IT helpdesk calls, increased physician satisfaction through improved workflows and improved HIPPA compliance with fast, No Click Access to applications.INTRODUCTION
Healthcare IT security firm Imprivata announced that it has deployed its OneSign single sign-on software to 91 National Health Service (NHS) Trusts in England, all NHS hospitals in Scotland, and four trusts in Northern Ireland. The company also said that its market share in the U.K. has grown rapidly, with recent customers including the Central and North West London NHS Foundation Trusts and Gloucestershire Hospitals NHS Foundation Trust. Imprivata also announced that it will be holding its 2012 U.K.
Physicians and nurses are on the front lines caring for patients while at the same time living through unprecedented change in their workflows due to HITECH and meaningful use. As a hospital’s IT organization rolls out technologies in support of meaningful use requirements, they are not just deploying systems; IT is effectively the catalyst for change working directly with clinicians and medical leadership to enhance overall care delivery.
Electronic prescribing of controlled substances (EPCS) delivers a number of benefits. It helps address prescription drug abuse by reducing “doctor shopping” and minimizing the risk of altered, stolen or fraudulent prescriptions. But to realize these benefits, healthcare organizations must implement EPCS systems that meet DEA requirements. However, these requirements present a potential challenge to implementation and physician adoption.
Revenue cycle professionals are challenged with improving the patient experience and reducing operating costs while complying with strict industry regulations.
The beginning point for achieving these goals is positive patient identification. Join your revenue cycle and patient access peers for an exclusive webinar to discover how biometric patient identification can improve your revenue cycle performance.